News
Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.
1d
TipRanks on MSNBuy/Sell: Wall Street’s top 10 stock calls this week
What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ...
Investors who bought WeBull (BULL) before last week gained 33.6%. However, after the market closed on Friday, July 18, the ...
1d
InvestorsHub on MSNSarepta shares drop after EU regulators reject Elevidys gene therapy
Shares of Sarepta Therapeutics Inc. (NASDAQ:SRPT) plunged 13% on Friday after a major regulatory blow in Europe. The European ...
StockStory.org on MSN5d
Why Privia Health (PRVA) Stock Is Up Today
Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors ...
Charles Schwab has expanded the list of securities available on its thinkorswim platform for overnight trading.
U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S.
U.S. stock indexes inched their way to more records Monday to kick off a week full of profit updates from big U.S. companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results